Kuros Biosurgery

Swiss medical technology and biotechnology company at Schlieren near Zurich, founded in 2000 as a spin-out of the federal institute of technology and listed on the Swiss exchange since 2016. Develops and sells bone graft substitutes for spinal and orthopaedic surgery, with its MagnetOs synthetic bone graft in granule, putty and strip forms, and works on biologically active fibrin based products and growth factor technologies for bone regeneration, selling through its own and partner sales channels in Europe and the United States.